Allergy Relief All Day (cetirizine hcl) NDC 55910-129

NDC codes

FDA NDC Directory

Product NDC (as listed)55910-129Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55910-0129Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
55910-129-45	55910012945	1 BOTTLE, PLASTIC in 1 BOX (55910-129-45) / 45 TABLET in 1 BOTTLE, PLASTICMarketed from May 17, 2013

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Allergy Relief All DaySuffix: All Day
Generic name (nonproprietary): cetirizine hcl
Active ingredients: Cetirizine hydrochloride — 10 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)
Product type: Over-the-counter drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078780
Marketing start: May 17, 2013
Marketing end: Jan 31, 2027
Other FDA classes: Histamine H1 Receptor Antagonists (Mechanism)
Identifiers: Product ID 55910-129_04bf0fbc-f3ea-4690-9edc-66d047b85724SPL ID 04bf0fbc-f3ea-4690-9edc-66d047b85724SPL set ID 27548729-7e2e-44cd-9a1d-70744f8b1df6RxCUI 1014678UNII 64O047KTOAUPC 0359726129459
Pharmacologic class: Histamine-1 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N455910012945 followed by a unit qualifier and the quantity

Package 55910-0129-45. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 1, 2025.

Indications (excerpt from the label)

Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 078780

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078780
Product	Strength	Form · route	Labeler	Product NDC
Cetirizine Hydrochloridecetirizine	Cetirizine hydrochloride 5 mg/1	TabletOral	Amneal Pharmaceuticals LLC	65162-045
Cetirizine Hydrochloridecetirizine	Cetirizine hydrochloride 10 mg/1	TabletOral	Amneal Pharmaceuticals LLC	65162-046
Cetirizine Hydrochloride Hives Reliefcetirizine	Cetirizine hydrochloride 5 mg/1	TabletOral	Amneal Pharmaceuticals LLC	65162-145